Radiology in the immune checkpoint inhibitor era

被引：0
|
作者：
Park, Benjamin C. [1 ,4 ]
Johnson, Douglas B. [2 ]
Lewandowski, Robert J. [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Gen Surg, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[3] Northwestern Mem Hosp, Dept Radiol, Chicago, IL 60611 USA
[4] Vanderbilt Univ, Med Ctr, 1161 21st Ave Med Ctr North,D-5203, Nashville, TN 37232 USA
来源：
CLINICAL IMAGING | 2024年 / 107卷
关键词：
Immune checkpoint inhibitors; Interventional oncology; Immune related adverse events; Oncologic imaging;
D O I：
10.1016/j.clinimag.2024.110080
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The field of oncology has undergone rapid changes following the introduction of immunotherapies and biologics. However, these changes have also created new roles for radiology in both diagnosis and treatment. Our article addresses the evolving role of radiology in the immune checkpoint inhibitor era of oncology. With the progression of new immunotherapies for cancer, imaging paradigms and image guided therapy options have changed. Multidisciplinary oncology teams should be aware of these opportunities for collaboration.
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitor-Associated Nephrotoxicity
    Mamlouk, Omar R.
    Danesh, Farhad
    NEPHRON, 2023, : 11 - 15
  • [32] Insight of immune checkpoint inhibitor related myocarditis
    Pi, Jin-kui
    Chen, Xiao-ting
    Zhang, Yan-jing
    Chen, Xue-mei
    Wang, Yin-chan
    Xu, Jia-yi
    Zhou, Jin-han
    Yu, Shuai-shuai
    Wu, Si-si
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [33] Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events
    Les, Inigo
    Martinez, Mireia
    Perez-Francisco, Ines
    Cabero, Maria
    Teijeira, Lucia
    Arrazubi, Virginia
    Torrego, Nuria
    Campillo-Calatayud, Ana
    Elejalde, Inaki
    Kochan, Grazyna
    Escors, David
    CANCERS, 2023, 15 (05)
  • [34] Management of immune checkpoint inhibitor-related rheumatic adverse events
    Zhou, Jiaxin
    Wang, Hanping
    Guo, Xiaoxiao
    Wang, Qian
    Duan, Lian
    Si, Xiaoyan
    Zhang, Li
    Liu, Xiaowei
    Li, Yue
    Zhang, Wen
    THORACIC CANCER, 2020, 11 (01) : 198 - 202
  • [35] Perspective: cancer vaccines in the era of immune checkpoint blockade
    Jonathan Cebon
    Mammalian Genome, 2018, 29 : 703 - 713
  • [36] Check this out: treatment paradigms in immune-checkpoint inhibitor colitis
    Kiparizoska, Sara
    Murphy, Megan E.
    Mattar, Mark C.
    CURRENT OPINION IN GASTROENTEROLOGY, 2023, 39 (01) : 43 - 49
  • [37] Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside
    Solimando, Antonio G.
    Crudele, Lucilla
    Leone, Patrizia
    Argentiero, Antonella
    Guarascio, Matteo
    Silvestris, Nicola
    Vacca, Angelo
    Racanelli, Vito
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [38] Diagnostic guide for immune checkpoint inhibitor-induced liver injury
    Ito, Takanori
    Takeuchi, Yasuto
    Mizuno, Kazuyuki
    Imai, Michitaka
    Yoshimaru, Yoko
    Abe, Kazumichi
    Abe, Masanori
    Matsuura, Takanori
    Yokode, Masataka
    Shiokawa, Masahiro
    Kodama, Yuzo
    Komuta, Mina
    Harada, Kenichi
    Tanaka, Atsushi
    HEPATOLOGY RESEARCH, 2024, 54 (08) : 719 - 726
  • [39] Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint Inhibitors
    Jean, Maxime Junior
    Samkoff, Lawrence
    Mohile, Nimish
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (01) : 42 - 65
  • [40] Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint Inhibitors
    Maxime Junior Jean
    Lawrence Samkoff
    Nimish Mohile
    Current Treatment Options in Oncology, 2024, 25 : 42 - 65
12345